Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARGX | ALNY | INSM | ||
| Company | Argenx Se ADR | Alnylam Pharmaceuticals | Insmed Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 916.15 | 468.29 | 204.68 | ||
| High | 917.00 | 473.50 | 206.55 | ||
| Low | 891.09 | 455.32 | 203.15 | ||
| Latest | 901.17 | 458.12 | 204.00 | ||
| Change | -14.80 | -7.22 | -1.04 | ||
| % Change | -1.62% | -1.55% | -0.51% | ||
| Volume | 228,630 | 627,331 | 2,160,126 | ||
| 20-Day Average Volume | 340,686 | 953,427 | 2,700,756 | ||
| Previous Close | 915.97 | 465.34 | 205.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 905.37 | 451.73 | 200.85 | ||
| 20-Day Raw Stochastic | 65.04% | 63.57% | 71.05% | ||
| 20-Day Relative Strength | 59.67 | 51.82 | 63.74 | ||
| Weighted Alpha | +58.15 | +81.06 | +179.36 | ||
| Today's Opinion | 88% Buy | 80% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.19% since 11/28/25 | +1.53% since 11/28/25 | -1.81% since 11/28/25 | ||
| Low | 886.24 on 12/01/25 | 448.27 on 12/01/25 | 202.68 on 12/04/25 | ||
| High | 934.62 on 12/03/25 | 479.79 on 12/03/25 | 212.75 on 12/02/25 | ||
| 1-Month | |||||
| %Chg | +8.27% since 11/05/25 | +5.42% since 11/05/25 | +9.16% since 11/05/25 | ||
| Low | 831.26 on 11/06/25 | 420.30 on 11/24/25 | 182.53 on 11/07/25 | ||
| High | 934.62 on 12/03/25 | 479.79 on 12/03/25 | 212.75 on 12/02/25 | ||
| 3-Month | |||||
| %Chg | +20.03% since 09/05/25 | +1.35% since 09/05/25 | +40.59% since 09/05/25 | ||
| Low | 698.92 on 09/25/25 | 417.00 on 11/05/25 | 134.01 on 09/26/25 | ||
| High | 934.62 on 12/03/25 | 495.55 on 10/20/25 | 212.75 on 12/02/25 | ||
| 6-Month | |||||
| %Chg | +55.22% since 06/05/25 | +48.74% since 06/05/25 | +180.45% since 06/05/25 | ||
| Low | 510.05 on 06/30/25 | 295.82 on 06/12/25 | 70.57 on 06/09/25 | ||
| High | 934.62 on 12/03/25 | 495.55 on 10/20/25 | 212.75 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 56,395,356 | 61,477,920 | 43,729,496 | ||
| Shares Outstanding, K | 61,569 | 132,114 | 213,273 | ||
| Annual Sales | 2,252,040,000 | 2,248,240,000 | 363,710,000 | ||
| Annual Net Income | 833,040,000 | -278,160,000 | -913,770,000 | ||
| Last Quarter Sales | 1,151,340,000 | 1,249,030,000 | 142,340,000 | ||
| Last Quarter Net Income | 344,260,000 | 251,080,000 | -370,020,000 | ||
| 60-Month Beta | 0.37 | 0.30 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.18 on 10/30/25 | 2.90 on 10/30/25 | -1.75 on 10/30/25 | ||
| Latest Earnings Date | 10/30/25 | 10/30/25 | 10/30/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 70.47 | 2,057.78 | 0.00 | ||